Rhonda Janice Pacheco

CEO

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 1 saleSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€250k

Latest filing published 12 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €250k. Read the official filing

Filing timeline

BuySale

Rhonda Janice Pacheco

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Rhonda Janice Pacheco: trading record in brief

Rhonda Janice Pacheco discloses dealings in Takeda Pharmaceutical Co Ltd to SEC (Form 4). The record holds 2 filings, for trades running from 1 July 2026 to 10 August 2026.

No open-market purchase appears, only 1 sale worth €250k. Outside the open market, there are 1 share grant.

The latest filing, published on 12 August 2026, reports an open-market sale of €250k in Takeda Pharmaceutical Co Ltd. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Rhonda Janice Pacheco

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Takeda Pharmaceutical Co Ltd (US)

Declarations2 total

▼

Rhonda Janice Pacheco

President, U.S. Business UnitExecutives10 Aug 2026Takeda Pharmaceutical Co Ltd

289,007 USD49SEC ↗

16,901 shares@ US$17.100.0005% mcap100.0% of flowAmerican Depositary SharesSEC:0001493152-26-037513:0

◆

Rhonda Janice Pacheco

President, U.S. Business UnitExecutives1 Jul 2026Takeda Pharmaceutical Co Ltd

0SEC ↗

50,156 shares0American Depositary SharesSEC:0001395064-26-000252:0

2 of 2 declarations

Rhonda Janice Pacheco: trading record in brief

Rhonda Janice Pacheco discloses dealings in Takeda Pharmaceutical Co Ltd to SEC (Form 4). The record holds 2 filings, for trades running from 1 July 2026 to 10 August 2026.

No open-market purchase appears, only 1 sale worth €250k. Outside the open market, there are 1 share grant.

Rhonda Janice Pacheco

Insider track record

Rhonda Janice Pacheco: trading record in brief

Companies and markets linked to Rhonda Janice Pacheco

Related entities

Rhonda Janice Pacheco

Insider track record

Rhonda Janice Pacheco: trading record in brief

Companies and markets linked to Rhonda Janice Pacheco

Related entities